Trials / Completed
CompletedNCT00363259
Pegintron Induction Therapy in HCV Non-Responders
Pegintron Induction Therapy in Previous Non-Responders With Chronic HCV: A Dutch Multicenter Randomized Controlled Trial. (PIT-Study)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (planned)
- Sponsor
- Foundation for Liver Research · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the sustained virological response rate at 24 weeks after the end of experimental treatment (induction and 72 weeks) to that of standard 48 weeks treatment with PEG-inteferon alfa-2b and ribavirin in patients with chronic hepatitis C previous unresponsive to interferon alfa monotherapy or interferon alfa/ribavirin combination therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Peginterferon alfa-2b | |
| DRUG | Ribavirin |
Timeline
- Start date
- 2002-07-01
- Completion
- 2005-11-01
- First posted
- 2006-08-15
- Last updated
- 2006-08-15
Locations
7 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00363259. Inclusion in this directory is not an endorsement.